- Report
- November 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- August 2024
- 135 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- July 2024
- 147 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- May 2024
- 128 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 135 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 139 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 130 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Report
- May 2024
- 140 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Clinical Trials
- April 2025
- 280 Pages
Global
From €2731EUR$3,000USD£2,319GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1138EUR$1,250USD£966GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1820EUR$2,000USD£1,546GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1138EUR$1,250USD£966GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more